Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-Guided Botulinum Toxin Injections for Post-Stroke Upper Extremity Spasticity
NCT05887479Phase 4Withdrawn
- Sponsor
- Şişli Hamidiye Etfal Training and Research Hospital
- Start
- May 2023
- Primary completion
- Jul 2023
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised trial of botulinum toxin type A in Spasticity (2 arms), sponsored by Şişli Hamidiye Etfal Training and Research Hospital. Primary endpoints: Visual Analog Scale for Pain at 2 weeks, Range of Motion at 2 weeks and 2 more. Planned start May 2023; status: withdrawn.
02
Drugs
botulinum toxin type A
03
Conditions
Spasticity
Beyond the preview
Go deeper on NCT05887479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05887479.